Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 25% ± 5% | |
astrocyte | 3 studies | 23% ± 7% | |
glutamatergic neuron | 3 studies | 31% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 352.57 | 966 / 966 | 100% | 17.34 | 527 / 527 |
ovary | 100% | 348.89 | 180 / 180 | 100% | 14.48 | 430 / 430 |
esophagus | 100% | 352.48 | 1443 / 1445 | 100% | 27.00 | 183 / 183 |
breast | 100% | 412.73 | 459 / 459 | 100% | 15.59 | 1115 / 1118 |
stomach | 100% | 279.40 | 358 / 359 | 100% | 22.32 | 286 / 286 |
bladder | 100% | 367.24 | 21 / 21 | 99% | 13.89 | 500 / 504 |
lung | 100% | 396.00 | 577 / 578 | 99% | 14.32 | 1147 / 1155 |
uterus | 100% | 410.55 | 170 / 170 | 99% | 11.50 | 453 / 459 |
skin | 100% | 550.65 | 1807 / 1809 | 99% | 16.21 | 466 / 472 |
prostate | 100% | 311.75 | 245 / 245 | 99% | 9.86 | 495 / 502 |
pancreas | 100% | 265.74 | 327 / 328 | 98% | 10.08 | 175 / 178 |
thymus | 100% | 550.37 | 653 / 653 | 97% | 8.59 | 587 / 605 |
kidney | 100% | 274.85 | 89 / 89 | 94% | 8.91 | 850 / 901 |
adrenal gland | 100% | 332.75 | 257 / 258 | 88% | 6.74 | 203 / 230 |
brain | 88% | 130.50 | 2330 / 2642 | 100% | 9.46 | 702 / 705 |
liver | 98% | 189.71 | 221 / 226 | 67% | 4.16 | 272 / 406 |
adipose | 100% | 414.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 368.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.01 | 29 / 29 |
muscle | 100% | 449.87 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 410.23 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.35 | 1 / 1 |
peripheral blood | 98% | 530.67 | 912 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 317.49 | 820 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 7.25 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032211 | Biological process | negative regulation of telomere maintenance via telomerase |
GO_0033234 | Biological process | negative regulation of protein sumoylation |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_1904816 | Biological process | positive regulation of protein localization to chromosome, telomeric region |
GO_0042254 | Biological process | ribosome biogenesis |
GO_0031647 | Biological process | regulation of protein stability |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005697 | Cellular component | telomerase holoenzyme complex |
GO_0016020 | Cellular component | membrane |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | GNL3L |
Protein name | G protein nucleolar 3 like G protein nucleolar 3 like (Guanine nucleotide binding protein-like 3 (Nucleolar)-like, isoform CRA_b) GNL3L protein Guanine nucleotide-binding protein-like 3-like protein |
Synonyms | hCG_1810878 |
Description | FUNCTION: Stabilizes TERF1 telomeric association by preventing TERF1 recruitment by PML. Stabilizes TERF1 protein by preventing its ubiquitination and hence proteasomal degradation. Does so by interfering with TERF1-binding to FBXO4 E3 ubiquitin-protein ligase. Required for cell proliferation. By stabilizing TRF1 protein during mitosis, promotes metaphase-to-anaphase transition. Stabilizes MDM2 protein by preventing its ubiquitination, and hence proteasomal degradation. By acting on MDM2, may affect TP53 activity. Required for normal processing of ribosomal pre-rRNA. Binds GTP. . |
Accessions | ENST00000674238.1 Q05DU1 Q9NVN8 ENST00000674311.1 ENST00000336470.8 ENST00000674178.1 A0A6I8PS19 ENST00000674229.1 A0A6I8PL80 ENST00000360845.3 A0A6I8PL58 ENST00000674420.1 A0A6I8PL53 ENST00000674498.1 ENST00000674225.1 |